# VABYSMO
> **BLA761235** · Biologics License Application · Sponsor: GENENTECH INC · Approved 2022-01-28
## Drug
- **FDA Application Number:** BLA761235
- **Application type:** Biologics License Application
- **Brand name:** VABYSMO
- **Generic name:** FARICIMAB
- **Active ingredients:** FARICIMAB-SVOA
- **Dosage form:** INJECTABLE
- **Route:** INTRAVITREAL
- **Marketing status:** Prescription
- **Sponsor:** GENENTECH INC
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2022-01-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761235)
---
*AI Analytics · CC0 1.0*